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https://doi.org/10.1016/j.stemcr.2018.01.042SUMMARYSo far, opposing outcomes have been reported following neonatal apex resection inmice, questioning the validity of this injurymodel to
investigate regenerative mechanisms. We performed a systematic evaluation, up to 180 days after surgery, of the pathophysiological
events activated upon apex resection. In response to cardiac injury, we observed increased cardiomyocyte proliferation in remote and
apex regions, neovascularization, and local fibrosis. In adulthood, resected hearts remain consistently shorter and display permanent
fibrotic tissue deposition in the center of the resection plane, indicating limited apex regrowth. However, thickening of the left ventricle
wall, explained by an upsurge in cardiomyocyte proliferation during the initial response to injury, compensated cardiomyocyte loss and
supported normal systolic function. Thus, apex resection triggers both regenerative and reparative mechanisms, endorsing this injury
model for studies aimed at promoting cardiomyocyte proliferation and/or downplaying fibrosis.INTRODUCTION
Cardiovascular diseases are the leading cause of death
worldwide (Mozaffarian et al., 2016), which is largely
attributed to the limited regenerative capacity of the
mammalian heart. However, this paradigm has been chal-
lenged by studies describing a developmental window for
heart regeneration in mammals. Although the first refer-
ence to mammalian heart regeneration was provided by
Mario Robledo in 1956 (Robledo, 1956), this concept
only became robustly supported in 2011 after Sadek and
colleagues demonstrated that murine hearts, when sub-
jected to apex resection during the first day of life, were
able to reestablish the myocardial tissue through activa-
tion of cardiomyocyte (CM) proliferation (Porrello et al.,
2011). This report proposed that, like lower vertebrates
(Flink, 2002; Poss et al., 2002), the mammalian heart
holds an intrinsic ability to regenerate from injury, which
could be exploited for therapeutic purposes. This work
also set the stage for several studies identifying regulators
of CM proliferation (Aurora et al., 2014; Bassat et al.,
2017; D’Uva et al., 2015; Heallen et al., 2013; Mahmoud
et al., 2013) or describing distinct injury models (Dare-
hzereshki et al., 2015; Haubner et al., 2012; Jesty et al.,860 Stem Cell Reports j Vol. 10 j 860–874 j March 13, 2018 j ª 2018 The Au
This is an open access article under the CC BY-NC-ND license (http://creativ2012; Lavine et al., 2014; Porrello et al., 2013; Uygur
and Lee, 2016).
In2014, controversyarosewhenanother laboratory,using
the same injury model, reported substantial scarring in the
resected apex region, which was accompanied by impaired
neovascularization and CM proliferation (Andersen et al.,
2014a). Further work by this group showed that fibrotic
tissue deposition in the resected region was definitive, and
that cardiac function was permanently reduced as animals
developed dilated cardiomyopathy, with left ventricle (LV)
chamber dilation andwall thinning (Andersen et al., 2016).
The reason for these contrasting findings is still unclear
(Andersen et al., 2014b; Kotlikoff et al., 2014; Sadek et al.,
2014), although technical variations such as injury severity
were shown to impact the formation of scar tissue upon
apex resection (Bryant et al., 2015) and cryoinjury (Dare-
hzereshki et al., 2015). Thus, the ability of neonatal hearts
to regenerate after apex resection seems to be dependent on
small technical variations which at present hampers prog-
ress in the field.
Additional difficulties are related to the evaluation of the
fibrotic scar (Andersen et al., 2014a; Bryant et al., 2015) and
the fact that the assessment of CM proliferation, the most
important hallmark for cardiac regeneration, is technicallythor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
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challenging. In particular, CM proliferation in mammals
can be easily mistaken for CM binucleation that initiates
around birth (reviewed in Zebrowski et al., 2016), an event
characterized by karyokinesis without cytokinesis, leading
to CM terminal differentiation (Soonpaa et al., 1996). Of
note, studies addressing the response to apex resection in
neonatal mice have either focused on functional assess-
ment or histopathological alterations (Andersen et al.,
2014a), but longitudinal studies examining cardiac remod-
eling, function, and the precise tissue response to injury
have not yet been performed.
Since there are antagonizing reports and because tissue
regeneration and repair often activate overlapping mecha-
nisms (Aurora et al., 2014; Tidball, 2011), we evaluated
both tissue responses following neonatal apex resection.
Hence, a systematic assessment of the pathophysiological
events occurring over 180 days after surgery was per-
formed. We found that apex resection triggers both regen-
erative (e.g. neovascularization and CM proliferation) and
reparative (e.g. cardiac fibrosis) mechanisms which result
in an adult heart with more CMs, benign adaptive cardiac
remodeling and restored systolic function.RESULTS
Establishment of Neonatal Apex Resection Injury
Model
One-day-old (P1) C57BL/6 mice were subjected to apical
resection by thoracotomy using the exposure of the LV
lumen as a standardized method for resection size (Mah-
moud et al., 2014; Porrello et al., 2011). Sham controls
underwent the same surgical procedure without resection
of the apex (no cardiac manipulation of any kind).
Immediately after the surgical procedure, the survival
rate of apex-resected animals was equivalent to sham con-
trols (87%). However, maternal cannibalization reduced
survival at 24 hr post-surgery to 61% and 82% for injury
and sham groups, respectively.
Hearts Are Not Fully Restored at the Histological Level
The ventricular surface area and heart length/body weight
ratio were significantly reduced upon apical resection byFigure 1. Hearts Do Not Fully Regenerate the Resected Apex
(A) Representative MT-stained sections of apex-resected and sham co
and/or cardiac fibrosis are highlighted by a dashed line. Scale bars, 2
21 days; A3, 60 days; and A4, 180 days) show collagen (blue staining
(B and C) Ventricular surface area (from left to right, n = 8, 10, 8, 14, 3
n = 11, 11, 8, 10, 4, 7, 4, 4) (C) of resected and sham-operated hearts
and 180 days post-surgery.
(D and E) Injury extension (from left to right, n = 8, 12, 7, 4) (D) an
(E) were calculated on MT-stained paraffin sections. All values are p
sections at 7 and 14 days after surgery, data on heart weight, heart t
862 Stem Cell Reports j Vol. 10 j 860–874 j March 13, 201811% and 14%, respectively (Figures 1A–1C), similar to
other reports (Andersen et al., 2014a; Porrello et al.,
2011). Representative sampling of the heart (Figure S1A)
and histological characterization by Masson’s trichrome
(MT) staining (Figures 1A and S1B) revealed that apex resec-
tion induced noticeable cardiac remodeling, with impact
on heart morphology and local deposition of fibrotic tissue
(Figures 1B–1D). From 7 to 21 days after surgery, apex
regrowth was evident as myocardial tissue was observed
below the resection site. Alongside, the myocardial tissue
in the innermost part of the apex where the lumen was
exposed, was surrounded by a subepicardial scar (Figures
1A and S1B). Higher magnification revealed that the scar
undergoes a maturation process, which starts with a scat-
tered deposition of collagenous material and matures to a
fibrillar appearance, occupying most of the central apex
wall from 60 days after resection onward (Figures 1A1–
1A4, S1B1, S1B2, and S1C). In contrast, areas surrounding
the central apex region displayed myocardial integrity.
Ventricular surface area was restored at 7 days after injury
(Figure 1B), and resected hearts weighed the same or
were even heavier than intact hearts (Figures S1D and
S1E). However, injured hearts were consistently shorter
throughout the study, indicating that heart growth was
mainly achieved through short-axis expansion (Figure 1C).
The extent of injury, estimated by determining the percent-
age of sections with cardiac damage (i.e., myocardial
disruption or cardiac fibrosis), decreased over time, which
correlates with an actual reduction in scar volume (Figures
1D and 1E). Overall, these results indicate that resected
hearts remain shorter, have permanent scarring, and do
not fully regenerate.Resected Hearts Are Functionally Competent
Echocardiograms at 21, 60, 120, and 180 days following
surgery confirmed that resected ventricles underwent se-
vere morphological alterations (i.e., long-axis shortening
and short-axis widening) (Figure 2A). However, in contrast
to previous reports (Andersen et al., 2016), our data showed
that short-axis expansion occurred due to a thickening of
the anterior and posterior wall of the LV (Figures 2B and
2C) and left ventricular chamber dilation (Figure 2D).ntrols following surgery. Sections exhibiting myocardial disruption
mm. High-magnification images of the injury site (A1, 0 day; A2,
) from 21 days onward. Scale bars, 250 mm.
, 7, 4, 4) (B) and heart length/ body weight (BW) (from left to right,
were determined in MT-stained paraffin sections at 0, 7, 14, 21, 60,
d ventricular and scar volume (from left to right, n = 19, 14, 7, 4)
resented as means ± SD. See also Figure S1 for representative MT
o BW ratio, and percentage of fibrosis in the apex.
(legend on next page)
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Because LV enlargement is concurrent to a reduction in
heart length (Figure 2E), the eccentricity index of injured
hearts was significantly increased (Figure 2F). End-diastolic
volume of injured hearts was increased at 21 days, but
normalized from 60 days onward (Figure 2G). Importantly,
no differences were detected in the ejection fraction (Fig-
ure 2H), stroke volume (Figure 2I) or cardiac output (Fig-
ure 2J) across groups, thus showing that the systolic func-
tion of injured hearts was not significantly impaired.
Regarding diastolic function, the ratio between LV early
(E) to late (A) filling velocities was marginally decreased
at 180 days, suggesting that incomplete relaxation and
increased filling pressures might be present in resected
hearts (Figure 2K). This can be explained by increased
myocardial stiffness caused by the scarring, wall thick-
ening, and/or alterations in ventricular chamber geometry.
Accordingly,myocardial performance index (also known as
Tei index), which comprises both systolic and diastolic pa-
rameters, showed a tendency to be increased in resected
hearts (Figure 2L) at the expense of longer relaxation times
(data not shown). Electrocardiogram (ECG) tracing of
injured hearts was similar to control animals (Figure 2M),
which was confirmed by the absence of any significant
modification in the evaluated ECG parameters (Table S1).
These findings demonstrate that, despite consistent LV
chamber enlargement and wall thickening, accompanied
by a reduced heart length, resected hearts are functionally
competent.
Short-Term Response to Cardiac Injury Involves
Extracellular Matrix Remodeling and Fibroblast
Activation
Apex amputation was evident by the disruption of the
expression pattern of sarcomeric-a-actinin (s-a-Actinin)
and laminin (LN) (Figure S2). Forty-eight hours after resec-
tion, the apex region was marked by the deposition of
fibronectin (FN) and tenascin-C (TN-C), and by an abun-
dant CD45+ immune cell infiltrate (Figures 3A and S2, ar-
rowheads). Myofibroblasts (a-SMA+ cells) also started to
appear at the injury site at this point (Figure S2, arrows).
Resolution of the inflammatory phase was evident at
7 days post-injury, whereas myofibroblasts became more
frequent (Figures 3A and S2). At 21 days post-resection,Figure 2. Injured Hearts Display Morphological Alterations but E
(A) Representative echocardiographic parasternal long-axis view 180
(B–G) End-diastolic left ventricle anterior wall thickness (LVAW), lef
diameter (LVID), heart length, eccentricity index, and heart volume.
(H–J) Ejection fraction (EF), stroke volume and cardiac output determ
(K and L) Ratio between left ventricular early (E) to late (A) filling vel
(from left to right, n = 7, 9, 22, 24, 18, 15, 18, 14).
(M) Representative ECG signal traces at 180 days post-surgery (n = 10
quantification of ECG parameters. All values are presented as means ±
864 Stem Cell Reports j Vol. 10 j 860–874 j March 13, 2018a-SMA was restricted to smooth muscle cells in vessels, as
observed in sham hearts. Of note, TN-C remained elevated
in the border between the resection and the adjacent
myocardium (Figure S2). Confocal microscopy analysis
further showed that FN and TN-C were produced by
CD45+ hematopoietic cells during the inflammatory phase
(48 hr post-surgery) and by a-SMA+ myofibroblasts dur-
ing inflammatory resolution (7 days post-surgery) (Fig-
ure 3A). Although largely overlapping, TN-C expression
was restricted to the interface between the healthy and
damaged myocardium, whereas FN displayed a more
ubiquitous deposition, suggesting different biological roles
(Figure 3A).
We profiled hematopoietic cells (CD45+) infiltrating
the apex and remote regions by flow cytometry at 2, 5,
and 7 days after surgery. Single-cell suspensions were
stained with antibodies to distinguish total myeloid
cells (CD11b+), macrophages (CD11b+F4/80+), monocytes
(CD11b+F4/80), neutrophils (CD11b+Gr-1+), T lympho-
cytes (CD3+), and B lymphocytes (CD45R+) (Figure S3A).
At 2 days after surgery, an influx of CD45+ cells was
observed in the apex, paralleled by a reduction in the
remote LV (Figures S3B and S3C). The rate of hematopoietic
cells in the myocardium of apex-resected hearts was com-
parable with those observed in sham-operated controls
at 7 days post-surgery, corroborating our immunofluores-
cence data. The immune infiltrate was mainly composed
of myeloid cells. At the initial stages of injury-response
(i.e., 2 days) neutrophils, monocytes, and macrophages in-
filtrated the myocardium at the apex, although only mac-
rophages remained elevated up to 5 days post-surgery.
No differences were observed regarding the percentage of
T lymphocytes between groups, whereas B lymphocytes
were significantly decreased 2 days post-injury (Figures
S3B and S3C). Additional staining of myeloid populations
allowed discrimination of CD11b+F4/80+Ly6Clo macro-
phages, CD11b+F4/80+Ly6Chi macrophages, CD11b+F4/
80Ly6Clo monocytes, and CD11b+F4/80Ly6Chi inflam-
matory monocytes, as reported previously (Aurora et al.,
2014). Of note, CD11b+F4/80+Ly6Chi macrophages and
CD11b+F4/80Ly6Chi monocytes were predominantly
increased at the injury site, but not in the remote myocar-
dium, during early inflammatory response (Figure S3D). Inxhibit Normal Systolic Function
days post-surgery.
t ventricle posterior wall thickness (LVPW), left ventricle internal
ined by Simpson’s method.
ocities and myocardial performance index (also known as Tei index)
, 6; 180 days sham, 180 days injury). See also Table S1 for detailed
SD.
(legend on next page)
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turn, CD11b+F4/80+Ly6Clo macrophages were increased at
5 days after injury, similar to what was reported following
myocardial infarction at P1 (Aurora et al., 2014).
Cardiac fibroblasts are master mediators of myocardial
remodeling following injury (reviewed in Souders et al.,
2009). However, studies determining the cardiac fibroblast
surface signature during the neonatal period are lacking.
Considering the heterogeneity of this cell type, we discrim-
inated fibroblast populations, from embryonic day 17 to
adulthood (Figure S4), through the expression of the
three well-reported markers of cardiac fibroblasts, i.e.,
CD90 (Thy-1), CD140a (PDGFRa), and SCA-1 (Furtado
et al., 2014; Hudon-David et al., 2007; McQualter et al.,
2009; Smith et al., 2011), following exclusion of non-
viable cells (PI+), endothelial cells (CD31+), hematopoietic
cells (CD45+), and erythrocytes (TER-119+). These results
demonstrated that fibroblasts express the mesenchymal
marker CD140a (R85%) at all stages analyzed, either
in the presence or absence of CD90 (Figure S4). Throughout
time these fibroblasts also acquire the expression of
SCA-1 and, thus, in the adult, the most abundant
subsets are CD140a+CD90SCA-1+ (Figure S4, green) and
CD140a+CD90+SCA-1+ (Figure S5, gray), as reported previ-
ously (Furtado et al., 2014).
We applied the same strategy to injured and sham-
operated animals 7 days post-surgery (Figure 3B). Three
main populations were identified: CD140a+CD90SCA-1
(blue; injury: 34.71% ± 2.24%; sham: 32.50% ± 2.72%),
CD140a+CD90+SCA-1 (purple; injury: 36.53% ± 0.95%;
sham: 40.29% ± 1.85%), and CD140a+CD90+SCA-1+
(gray; injury: 21.26% ± 1.15%; sham: 17.77% ± 1.40%). A
minor population was also found expressing CD90 only
(red; injury: 3.79% ± 0.94%; sham: 6.34% ± 1.17%),
whereas SCA-1 wasmainly confined to cells also expressing
the other surfacemarkers (Figure 3B). No statistically signif-
icant differences were detected in the relative percentages
of each population between injured animals and sham-
operated controls (Figure 3B). This might be explained
by the use of the whole heart and/or by variability created
during the isolation procedure, which may mask small
differences in cell numbers in the apex. Indeed, immuno-
fluorescence results showed a fibroblast-mediated responseFigure 3. Apex Resection Triggers Local ECM Remodeling and Fibr
(A) Representative confocal images of CD45/TN-C/FN, a-SMA/TN-C/FN
(n = 4) and 7 days post-surgery (n = 4). Arrowhead, CD45+ hematopoie
line. Scale bars, 30 mm. See also Figure S2 for detailed analysis of ce
(B) Cardiac fibroblasts were isolated and prospectively identified by
Figure S4), 7 days post-resection (n = 3) and sham surgery (n = 6). CD1
and CD140a+CD90+SCA-1+ (gray/SP3) fibroblasts were FACS-sorted (se
(C) Transcriptomic profiling of SP1 to SP3 subpopulations isolated from
qPCR. Expression levels were normalized against Gapdh. All values are
phenotypic characterization of cardiac fibroblasts throughout ontoge
866 Stem Cell Reports j Vol. 10 j 860–874 j March 13, 2018to injury largely confined to the lesion site (Figures 3A
and S2).
The activation of most abundant populations was
assessed by real-time qPCR (sorting strategy detailed in Fig-
ure S5). The CD140a+CD90+SCA-1 (purple, SP1) subpopu-
lation, which is particularly frequent in earlier develop-
mental periods (Figure S4), responded to apex resection
by upregulating genes associated with scarring (Col1a1,
Col3a1, Tgfb1, and Tgfb3), CM proliferation (Fn1, Tbx20,
Igf1, Igf2, and Fstl1), and neovascularization (Vegfa) (Fig-
ure 3C). In contrast, CD90+CD140a+SCA-1+ (gray, SP3)
cells, a subpopulation upsurging after birth (Figure S4),
shows a repair-associated phenotype, with increased
expression of Col1a1, Col3a1, Tgfb1, and Tgfb3 (Figure 3C).
CD140a+CD90SCA-1 (blue, SP2) cells, more frequent in
earlier developmental periods (Figure S4), were not respon-
sive to injury, although they exhibited high expression
levels of most evaluated transcripts (Figure 3C). These
findings indicate that development-associated fibroblasts
support the regenerative response, whereas fibroblast
subsets abundant in adulthood signal mostly toward scar
formation.
CM Proliferation Is Induced upon Cardiac Injury and
Leads to Newly Formed CMs
The activation of CM proliferation after apex resection has
been a matter of intense debate (Zebrowski et al., 2016).
At 7 days post-injury, immunostaining for histone H3
phosphorylated at serine 10 (PH3) and s-a-Actinin high-
lighted cycling CMs that were distributed throughout the
myocardium. Quantification of PH3+ CMs in the myocar-
dium below the papillary muscle and in isolated CMs
from the same region showed that injured hearts displayed
increased rates of mitotic CMs (PH3+) in comparison with
sham-operated hearts (Figures 4A and 4B). Moreover,
CMs undergoing mitosis show sarcomere disruption,
which is essential for effective cell division (Figures 4C
and S6A; Movies S1, S2, and S3). These findings were
further supported by a significant increase in CMs
displaying Aurora B kinase in the nucleus and in the cleav-
age furrow, of the border zone and remote myocardium, of
resected hearts, indicating efficient cytokinesis (Figures 4Doblast Activation
, and s-a-Actinin/TN-C/FN immunolabelling at the injury site 48 hr
tic cells; arrows, a-SMA+ myofibroblasts; dashed segment, resection
llular and extracellular matrix (ECM) remodeling following injury.
CD140a, CD90, and SCA-1 expression throughout ontogeny (see
40a+CD90+SCA-1 (purple/SP1), CD140a+CD90SCA-1 (blue/SP2),
e Figure S5 for sorting strategy).
injured (n = 5) and sham hearts (n = 4) was performed by real-time
presented as means ± SEM. See also Figures S4 and S5 for detailed
ny and sorting strategy, respectively.
Figure 4. Activation of CM Proliferation and Not Binuclea-
tion Generates a Heart with Increased CM Number upon
Apex Resection
(A and B) Quantification of PH3 expression by CMs in the area
between papillary muscles and the apex (A) (n = 10, 10; 7 days
sham, 7 days injury) and of isolated CMs from the same region
(B) (n = 12, 11; 7 days sham, 7 days injury).
(C) Representative confocal image and respective orthogonal
views of a CM expressing PH3 and clearly displaying sarcomere
disassembly. Scale bar, 20 mm. See also Movies S1, S2, and S3.
(D) Quantification of Aurora B expression in CMs in regions
close to the apex and remote myocardium (n = 3, 3; 7 days
sham, 7 days injury).
(E) Representative image of Aurora B expression in prolifer-
ating CMs at 7 days post-surgery (n = 3). Scale bar, 20 mm.
(F) Assessment of CM nucleation in the apex region at 7 days
post-surgery and representative images (n = 5, 4; 7 days sham,
7 days injury).
(G) Ratio between round-shaped (immature) and rod-shaped
(mature) CMs in mononucleated and multinucleated sub-
populations of CMs isolated from the apex (n = 6, 5; 7 days
sham, 7 days injury).
(H) Three EdU pulses (days 1, 6, and 8) were given to trace
proliferating CMs. Hearts were harvested 14 days post-surgery.
(I) Representative confocal images of PCM-1+EdU+ CM 14 days
post-surgery. Scale bars, 40 mm.
(J) Quantification of EdU incorporation in PCM-1+ CMs in the
apical and remote myocardium (n = 4, 7; 14 days sham,
14 days injury).
(K) CM nucleus density at 14 days post-surgery (n = 4, 7;
14 days sham, 14 days injury).
(L) Representative confocal image of COLL IV expression in
the myocardium, which allowed the delineation of CM cell
boundaries and nucleation evaluation (n = 4, 7; 14 days sham,
14 days injury). Scale bar, 30 mm.
(M) Stereological estimate of the total number of CMs in the
myocardium (n = 4, 7; 14 days sham, 14 days injury). All
values are presented as means ± SD.
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and 4E). Close to the injury, mitotic CMs were found pre-
dominantly near FN, but not TN-C. In accordance, CD29
(b1 integrin), which forms an integral part of several integ-
rins involved in cell-matrix interactions, was found inmost
CMs (Ieda et al., 2009) (Figure S6).
The loss of CM proliferative potential is commonly
attributed to the progression to a terminally differentiated
phenotype characterized by the presence of amature sarco-
meric apparatus and binucleation (Collesi et al., 2008). To
assess whether increased rates of mitosis correlated with
higher rates of CM proliferation rather than multinuclea-
tion, we assessed the number of nuclei and morphometric
parameters of CMs isolated from the apex by imaging flow
cytometry. Injured hearts showed less multinucleation and
a significant increase of mononucleated and round-shaped
CMs, attesting successful cell-cycle progression and cell
division (Figures 4F and 4G).
Next,weapplied stereologytoestablishwhether theprolif-
erative upsurge observed uponapex resection impacts on to-
tal CM numbers. The mice were treated with the thymidine
analog 5-ethynyl-20-deoxyuridine (EdU), and the frequency
of EdU incorporation in thick tissue sectionswas determined
by co-labeling with PCM-1, a marker of CM nuclei (Fig-
ure 4H). The number of EdU+ CMs was greater in resected
hearts relative to sham-operated controls (Figures 4H–4J),
further supporting an increment in CM proliferation after
injury. AlthoughCMproliferationwas observed throughout
the LV, the frequency of EdU+ CMswasmore pronounced in
regions proximal to the apex, comparedwith remote regions
(Figure 4J). In accordance, the density of myocyte nuclei
was found to be significantly increased in the apex regions
(Figure 4K). Combination of collagen type IV (COLL IV),
to delineate cell boundaries, with PCM-1 immunolabelling,
showed that CM binucleation in injured (95.7% ± 0.93%)
and sham-operated hearts (95.98% ± 0.86%) was similar at
14 days after surgery (Figure 4L).
Taking multinucleation into account, we determined
the density of CMs in the tissue. The volume of the LV
was calculated based on morphometric analysis of longitu-
dinal tissue sections (Figure S1A) and corrected for tissue
shrinkage during fixation and processing for paraffin
embedding. The total number of LVCMs in resected hearts,
calculated based on CM density in the remote region, was
significantly higher relative to sham-operated controls (Fig-
ure 4M). These findings show that the injury-activated CM
proliferation burst, althoughmore abundant in the apex, is
also extended to remote regions, overcompensating the
amount of CM loss after resection.
Resected Hearts Display Increased Capillary Density
and No Signs of CM Hypertrophy or Edema
To evaluate the status of the capillary network, endo-
thelial cells (CD31+) were quantified 60 days after surgery.868 Stem Cell Reports j Vol. 10 j 860–874 j March 13, 2018The number of CD31+ endothelial cells was significantly
increased in injured hearts in comparison with sham-oper-
ated animals both in the apex and in the remote myocar-
dium (Figures 5A and 5B).
To further establish whether hypertrophy was also
contributing for LV wall expansion, CM size was assessed
in tissue sections and isolated CMs. No significant alter-
ations were detected in the cross-sectional area of CMs
over time and in different ventricular regions, apart from
the vicinity of fibrotic tissue, where CMs had a larger
cross-sectional area at 180 days post-surgery (Figures 5C
and 5D). Corroborating these findings, no significant differ-
ences were found in the area and volume of isolated CMs,
suggesting that this hypertrophic behavior is residual and
mainly localized in the apex (Figures 5E–5H). Furthermore,
as edema could also explain the increase in myocardial vol-
ume, through the accumulation of fluid in the extracellular
interstitial space, we examined the myocardial water con-
tent at 180 days post-surgery, but no differences were de-
tected between the two groups (Figure 5I). Overall, these re-
sults further support that the LVwall thickening in resected
hearts results from an increase in the number of CMs and
is thus a consequence of injury-activated proliferation.DISCUSSION
Sadek and colleagues reported that apex-resected murine
hearts at P1 displayed regenerative capacity (Porrello
et al., 2011). Others have thereafter described a lack of his-
tological restoration, with formation of a fibrotic scar, ulti-
mately leading to LV dilation and reduced systolic function
(Andersen et al., 2014a, 2016). We performed a detailed
evaluation of cellular and histo-functional alterations up
to 180 days after resection and showed a well-orchestrated
response in which a combined action of regenerative
and reparative mechanisms is triggered, culminating in
myocardial growth alongside fibrosis deposition in the
innermost part of the apex. Therefore, our results are
neither compatible with full regeneration (Porrello et al.,
2011) nor exclusively with repair (Andersen et al., 2014a,
2016), rather showing an intermediate response which
likely explains the opposing reports in the field.
As previously debated, the methodology employed dur-
ing surgery and in the assessment of the extent of regener-
ation is determinant for obtaining reliable results and
outcomes (Andersen et al., 2014b; Sadek et al., 2014).
Similar to other authors (Mahmoud et al., 2014; Porrello
et al., 2011), we used LV cavity exposure as a standardized
method for the resection. The resultant injury, assessed
by measuring the ventricular surface area, as in Porrello
et al., was 11% of the LV and therefore less severe than
the 15% reported in their study.
Figure 5. Resected Hearts Display Increased Coronary Vasculature but Not Hypertrophy or Edema
(A and B) Capillary density at 60 days post-surgery (i.e., number of CD31+ endothelial cells per unit area) (n = 6, 7; 60 days sham, 60 days
injury). Scale bars, 10 mm.
(C and D) CM cross-sectional area at 60 and 180 days post-surgery (n = 6, 6, 4, 4; 60 days sham, 60 days injury, 180 days sham, 180 days
injury). Scale bars, 25 mm.
(E and F) Area of isolated CMs at 60 and 180 days post-surgery (n = 3, 5, 4, 4; 60 days sham, 60 days injury, 180 days sham, 180 days injury).
Scale bar, 100 mm.
(G) Volume of isolated CMs at 60 days post-surgery (n = 4, 6 sham, injury).
(H) Representative images of 3D segmentation of CMs. Scale bars, 50 mm.
(I) Myocardial edema was assessed by myocardial water content quantification (i.e., percentage of myocardial weight that is lost after
desiccation) 180 days post-surgery (n = 10, 6; 180 days sham, 180 days injury). All values are presented as means ± SD.
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By quantifying (1) the incidence of sarcomere-disas-
sembly associated with PH3, (2) EdU+ CMs in a pulse-chase
experiment, and (3) Aurora B kinase in the nuclei and
cleavage furrow of CMs, we showed that CMs of resected
hearts exhibit increased mitotic rates, accompanied by
cytokinesis. During the first week of post-natal life in
mice the majority of CMs binucleate, exit from the cell cy-
cle, and continue to grow in size (Soonpaa et al., 1996).
Several lines of evidence support that proliferating CMs
are mononucleated and that binucleation marks an end
to cell-cycle activity during development (Bersell et al.,
2009; Paradis et al., 2014). By analyzing isolated CMs by
imaging flow cytometry we found that, 7 days following
apex resection, CM binucleation is reduced and accompa-
nied by an increase in the pool of mononucleated round-
shaped CMs, further supporting that, in response to injury,
CMs undergo karyokinesis and cytokinesis. At 14 days
post-resection the levels of binucleation were already com-
parable with sham-operated animals, meaning that newly
formed CMs follow a normal maturation progression.
These results contrast with a decrease in CM mitotic activ-
ity after injury observed by Andersen et al., in which a sin-
gle EdU injection was administered at the onset of surgery,
most likely missing the CM proliferative burst. In a recent
publication, apex resection was shown to promote a tran-
sient acceleration in binucleation, an event no longer
noticeable at P8 (Zebrowski et al., 2017). According to
this study, a lower number of CMs would be expected in
hearts subjected to apex amputation, which was not ad-
dressed by the authors. Herein, total CM numbers, as esti-
mated by stereology, were increased in resected hearts
compared with sham controls, indicating that themajority
of injury-induced CM cell-cycle activity results in prolifer-
ation, not binucleation. In the work by Zebrowski and col-
leagues, isolated CMs were identified by sarcomeres in
phase contrast, an approach that may be adequate to iden-
tify mature (rod-shaped) CMs, but is inefficient for the
identification of immature (round-shaped) CMs with
less-developed sarcomeres. By bypassing the use of a CM-
specific marker, the authors most likely overestimated
binucleation, particularly in resected hearts, which display,
according to our results, higher rates of round-shaped
mononucleated CMs.
Cardiac fibroblasts are typically activated following
injury, and their role in directing pathological disease re-
modeling is well recognized. Nonetheless, while adult fi-
broblasts induce hypertrophy, fetal fibroblasts promote
CM proliferation and thus contribute to ventricular cham-
ber enlargement in late development (Ieda et al., 2009). By
combining the expression of three cell surface markers, we
discriminated the main fibroblast subsets at different
developmental stages and after cardiac injury. In response
to injury, the fibroblast population, abundant at younger870 Stem Cell Reports j Vol. 10 j 860–874 j March 13, 2018ages (CD140a+CD90+SCA-1), upregulated genes associ-
ated with the production of extracellular matrix, neovascu-
larization, and secreted factors known to activate CM
proliferation. In contrast, the fibroblast subset that is
more frequent during adulthood (CD140a+CD90+SCA-1+)
mainly upregulated transcripts associated with fibrotic
mechanisms. Altogether, these findings suggest that
neonatal fibroblasts may display an intermediate pheno-
type between fetal and adult fibroblasts, potentially able
to support both fibrogenesis and regeneration.
Earlier studies on neonatal apex resection lacked func-
tional longitudinal studies in which the same heart is
analyzed over time. Herein we paralleled the histological
analysis with detailed functional evaluation by echocardi-
ography. In contrast to Porrello et al. (2011), we observed
the formation of fibrotic tissue in all analyzed hearts,
which, in most cases, matured to a full-thickness scar as re-
ported by others (Andersen et al., 2014a; Bryant et al.,
2015). These contrasting observations are most likely a
result of incomplete histological sampling in the former
study, as shown previously (Andersen et al., 2014b). In
our work, we increased sampling robustness by analyzing
serial sections of the whole heart. Interestingly, while the
heart weight and volume increased over time, as during
normal heart growth, the scar volume diminished, indi-
cating that the affected regionwas at least partially replaced
by new myocardium. However, injured hearts remained
shorter throughout the study, and thus the removed apex
was not fully restored.
Andersen et al. (2016) performed a long-term analysis of
ventricular function, using F-18-fluorodeoxyglucose posi-
tron emission tomography (FDG-PET). In this study,
abnormal systolic function, short-axis enlargement and
local wall thinning were demonstrated in resected hearts
180 days post-surgery, leading to the conclusion that ani-
mals developed dilated cardiomyopathy. Herein, although
a tendency for reduced systolic function was evident
21 days post-surgery, no statistical differences were
observed between groups over 180 days, indicating that
injured hearts became functionally competent at the sys-
tolic level. Widening of resected hearts occurred through
chamber expansion and LV wall thickening, which is not
compatible with dilated cardiomyopathy, rather resem-
bling an eccentric hypertrophy phenotype. The distinct re-
sults obtained from our work and Andersen et al. (2016)
may reflect differences in the methodology used. While
FDG-PET is particularly valuable for assessingmetabolic ac-
tivity, the spatial resolution of the equipment (1 mm)
falls short to precisely quantify LVwall thickness compared
with the high-resolution echocardiography (50 mm) (Gar-
giulo et al., 2012) used in our study. Moreover, a reduction
in wall thickness was only significantly different in 1 of the
20 analyzed ventricular segments, which hardly explains a
Figure 6. Proposed Model of the Biological Response Elicited by Neonatal Apex Resection
Apex resection promotes local infiltration of inflammatory cells in the first 48 hr, which leads to the deposition of a transient FN and TN-C-
rich ECM. At 7 days post-injury, rates of CM proliferation are increased throughout the left ventricular myocardium and cardiac fibroblasts
are activated at the injury site. These cellular dynamics result in a thickening of left ventricle walls, de novo vessel formation and
deposition of a permanent fibrotic scar at the midpoint of the injured area. Long-term evaluation showed preserved systolic function,
shortened long-axis and thicker left ventricle, without hypertrophy and edema.dilated cardiomyopathy phenotype. The authors also
missed to demonstrate progressive loss of function, typi-
cally found in small animal models of this disease (Cama-
cho et al., 2016).
Pertinent questions have been recently raised regarding
the value of neonatal apex resection to identify factors
important for adult heart regeneration/repair. Although
we cannot put forward conclusions on the response elicited
by other injury models, our results indicate that P1 hearts
subjected to mechanical trauma are capable of under-
going neomyogenesis and neovascularization, despite local
fibrosis (Figure 6). In our view, these findings endorse this
injury model as particularly valuable for studies aiming to
block fibrosis, in favor of conditions stimulating CMprolif-
eration and functional cardiac regeneration.EXPERIMENTAL PROCEDURES
Supplemental Experimental Procedures are available with a
detailed description of our experimental procedures.
Animals and Apex Resection Injury Model
All animal work was approved by the IBMC-INEB (Instituto de
Biologia Molecular e Celular–Instituto de Engenharia Biomédica)
Animal Ethics Committee, and by the Direcção Geral de Veteri-
nária (permit 022793), and is in conformity with Directive 2010/
63/EU. Humane endpoints were followed in accordance with the
OECD Guidance Document on the Recognition, Assessment, and
Use of Clinical Signs as Humane Endpoints for Experimental
Animals Used in Safety Evaluation.
P1 C57BL/6mice were anesthetized by hypothermia for3min.
Animals were laid in lateral decubitus position, the skin cut, thethorax was opened in the fourth intercostal space and the ventric-
ular apex was resected (removing a minimal amount of tissue but
ensuring lumen exposure). Subsequently, the ribs and skinwere su-
tured and animals were exposed to heat produced by an infrared
lamp to revert anesthesia and returned the progenitor. Sham-oper-
ated animals underwent the same procedure with the exception of
apex resection.
Histological Characterization
At 0, 7, 14, 21, 60, 120, and 180 days after surgery, apex-resected
and sham-operated hearts were harvested and processed for
paraffin-embedding (see Supplemental Experimental Procedures
for detailed information). Hearts were sectioned longitudinally in
3 mm sections and sampled according to Figure S1A. Subsequent
histological MT staining was used to assess apex re-growth, fibrosis
deposition, and injury extension.
Immunofluorescence
Immunofluorescence was performed in cryosections (0 day, 48 hr,
5 days, 7 days, 14 days, and 21 days after surgery), in histological
sections (60 days post-surgery), and in cytospins of isolated CMs;
as detailed in the Supplemental Experimental Procedures. Assem-
bly,merging, and contrast/brightness adjustments were performed
in Fiji v2.0.0-rc-54/.51h. software.
Flow Cytometry and Fluorescence-Activated Cell
Sorting
Single-cell suspensions were prepared following digestion of car-
diac tissue with crude collagenase (C2139, Sigma-Aldrich). Cells
were incubated with fluorescence-conjugated antibodies or with
the respective isotype controls for 30 min on ice and protected
from light. Nonviable cells were excluded by adding 0.5% propi-
dium iodide (P4170, Sigma-Aldrich) to cell suspension prior toStem Cell Reports j Vol. 10 j 860–874 j March 13, 2018 871
analysis in a FACSCanto II cytometer (BD Biosciences). Data anal-
ysis was performed in FlowJoVX software. The threemost frequent
fibroblast subsets were isolated by FACSAria (BD Biosciences), as
described in Supplemental Experimental Procedures and in Fig-
ure S5. See also Figure S3 for detailed characterization of the inflam-
matory infiltrate.
Real-Time qPCR
Total RNA was isolated from FACS-sorted cells using the RNeasy
Mini Kit (QIAGEN). cDNA was obtained resorting to PrimeScript
RT reagent Kit (Takara) and pre-amplified using SsoAdvanced
PreAmp Supermix (Bio-Rad). Real-time qPCR were performed by
using iQ SYBR Green Supermix (Bio-Rad) and according to the
iQ5 Real-Time PCR Detection System (Bio-Rad). Primer sequences
and temperature cycles are described in Supplemental Experi-
mental Procedures. mRNA expression was defined as primer effi-
ciency to the power of the difference in threshold cycle values
between the reference (Gapdh) and the genes of interest.
EdU Pulse-Chase Assay
Neonates were subcutaneously injected with 25 mg/g of animal of
EdU (C10640, Sigma-Aldrich) immediately after surgery and on
days 5 and 7 after surgery. Hearts were harvested at 14 days post-
surgery and LV subdivided in apex and remote myocardium,
each sampled in 2 mm fragments before cryosectioning (40 mm).
EdU incorporation was detected using the Click-iT reaction
cocktail in accordance with manufacturer instructions (C10640,
Sigma-Aldrich) followed by PCM-1 immunolabelling and DAPI
counterstain. Images were acquired in a Leica TCS SP5 laser
scanning confocal microscope. Tissue fragments (8–10) from
both regions were quantified per animal with assistance of FIJI
v2.0.0-rc-54/.51h and IMARIS 8.4.1. The total number of CMs
was estimated by adapting the two-step NV 3 VREF method (Alkass
et al., 2015), where NV is an estimate of PCM-1 density and VREF is
the volume of themyocardiumat 14 days post-surgery.Myocardial
volume was determined by multiplying the area of the myocar-
dium in each histological longitudinal section by the distance
separating adjacent sections in 14 days post-surgery hearts. This
value was corrected for tissue shrinkage during fixation and pro-
cessing for paraffin embedding.
CM Isolation
CMs were isolated at 7, 60, and 180 days post-surgery. Neonatal
CMs were isolated as described previously (Mollova et al., 2013),
with the following alterations: CMs were fixed in 4% paraformal-
dehyde at room temperature (RT) for 2 hr and digested with
3 mg/mL collagenase type II (Worthington). Adult CMs were iso-
lated by reperfusion in a Langendorff system (80 mmHg and at
3mL/min for 25–30min) with Liberase TM (05401127001, Roche;
13.3 mg/mL) and Trypsin (27250018, Gibco; 13.8 mg/mL), and fixed
in 4% paraformaldehyde in PBS.
Imaging Flow Cytometry
Cells were permeabilized with 13 BD Perm/Wash buffer during
15 min at RT. Incubations with primary and secondary antibodies
lasted 2 and 0.5 hr on ice, respectively. Antibodies were diluted
in 13 BD Perm/Wash. Immediately before acquisition in872 Stem Cell Reports j Vol. 10 j 860–874 j March 13, 2018ImageStreamX cells were filtered and nuclei stained with 200 mM
DRAQ5 (BioStatus).
Statistical Analysis
IBMSPSS Statistics 24was used for statistical analysis. Shapiro-Wilk
test was used to evaluate normal distribution of data. Outliers were
excluded fromthe statistical analysis.Homoscedasticityof the sam-
ple was tested by Levene’s test, which defined the statistical test(s)
applied. Normally distributed and homocedastic data were tested
with independent sample Student’s t test and one-way ANOVA
for two or three or more groups, respectively. Tukey’s post-hoc test
for correction of multiple comparisons was performed whenever
significant differences were found between three or more groups.
Non-normally distributed and/or heterocedastic data were tested
with Mann-Whitney U test and Kruskal-Wallis one-way ANOVA
for two or three or more groups, respectively. Again, multiple com-
parisons were performed when three or more groups were consid-
ered statistically different. The statistical significance level chosen
for all statistical tests was p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, six figures, one table, and three movies and can be
found with this article online at https://doi.org/10.1016/j.stemcr.
2018.01.042.
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